This randomized, open-label, parallel-controlled trial investigated the efficacy and safety of needle-free injection (NFI) compared to conventional insulin pen (CIP) in patients with type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback